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Yeast Cdc48 (p97/VCP in human cells) is a hexameric AAA
ATPase that is thought to use ATP hydrolysis to power the
segregation of ubiquitin-conjugated proteins from tightly
bound partners. Current models posit that Cdc48 is linked
to its substrates through adaptor proteins, including a
family of seven proteins (13 in human) that contain a
Cdc48-binding UBX domain. However, few substrates for
specific UBX proteins are known, and hence the general-
ity of this hypothesis remains untested. Here, we use
mass spectrometry to identify ubiquitin conjugates that
accumulate in cdc48 and ubx mutants. Different ubx mu-
tants exhibit unique patterns of conjugate accumulation
that point to functional specialization of individual Ubx
proteins. To validate our findings, we examined in detail
the endoplasmic reticulum-bound transcription factor
Spt23, which we identified as a putative Ubx2 substrate.
Mutant ubx2 cells are deficient in both cleaving the ubiq-
uitinated 120 kDa precursor of Spt23 to form active p90
and in localizing p90 to the nucleus, resulting in reduced
expression of the target gene OLE1, which encodes fatty
acid desaturase. Our findings provide a resource for fu-
ture investigations on Cdc48, illustrate the utility of pro-
teomics to identify ligands for specific ubiquitin receptor
pathways, and uncover Ubx2 as a key player in the regu-
lation of membrane lipid biosynthesis. Molecular & Cel-
lular Proteomics 12: 10.1074/mcp.M113.030163, 2791–
2803, 2013.
Budding yeast Cdc48 is an essential, highly abundant
member of the AAA (ATPase associated with various cellular
activities) protein family. Cdc48 has been linked to numerous
functions throughout the cell but is best known for its critical
role in ERAD (endoplasmic reticulum associated protein deg-
radation)1, which occurs via the ubiquitin proteasome system
(UPS). It is also involved in cell-cycle progression, homotypic
membrane fusion, chromatin remodeling, autophagy, and
transcriptional and metabolic regulation (1–4). Human Cdc48,
known as p97 or VCP, has been the subject of much attention
over the last few years because of its causal links to amyo-
trophic lateral sclerosis and inclusion body myopathy, Paget’s
disease of the bone, and frontotemporal dementia as well as
its implied role in a variety of diseases including cancer (5–9).
As a result, p97 has been the target of multiple drug devel-
opment efforts (10, 11).
Cdc48/p97 interacts with a large number of putative sub-
strate adaptors and cofactors, including a family of proteins
(seven in yeast, 13 in human cells) that contain a UBX domain
(12, 13). The UBX domain binds to the N-terminal region of
p97 and proteins bearing this domain have been suggested to
serve as interchangeable adaptors that target Cdc48/p97 to
specific substrates. Although the functions and mechanism of
action of Cdc48/p97 remain poorly understood, it is generally
presumed that it uses ATP hydrolysis to fuel the extraction of
ubiquitinated proteins from multisubunit complexes or mem-
branes as a prelude to their degradation by the proteasome.
Cdc48/p97 may also remodel protein–protein and protein–
nucleic acid complexes in a manner that is not coupled to
either prior ubiquitination (14) or subsequent degradation by
the proteasome (15, 16).
Based on the abundance of Cdc48/p97 and the complexity
of the network of adaptor proteins for which it serves as the
hub, Cdc48/p97 has the potential to exert a profound influ-
ence on the UPS. However, the number of known substrates
of Cdc48/p97 remains relatively small, and smaller still is the
number of substrates that have been linked to a specific UBX
domain protein. Indeed, only a handful of specific cases are
known, and in half of them proteasomal degradation is not the
final outcome (15–22). To understand why there is such a
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profusion of UBX domain proteins in cells, it will be important
to determine what these proteins do to their substrates, which
will require knowing what their substrates are. Therefore, a
major goal of this work was to enable future investigations into
the function and regulation of UBX proteins by assembling a
catalogue of candidate substrates/targets.
A key paradigm that guides our current understanding of
Cdc48 function emerged from studies on the processing of
the transcription factors Spt23 and Mga2 (23–25). These sem-
inal studies revealed the mechanism by which cells control
their ratio of saturated to unsaturated fatty acids to maintain
an appropriate lipid composition in cellular membranes. Cen-
tral to this regulation are the transcription factors Spt23 and
Mga2, which are released from the endoplasmic reticulum
(ER) membrane and translocate to the nucleus to activate
expression of OLE1, which encodes the stearoyl-9 desatu-
rase that governs the conversion of saturated fatty acids
(SFAs) to unsaturated fatty acids (UFAs) (26, 27). Spt23 and
Mga2 are initially produced as 120 kDa precursors (p120)
embedded in the ER by C-terminal signal or anchor domains,
such that the bulk of each protein projects into the cytosol.
The p120 form of each protein is ubiquitinated by Rsp5 and
cleaved by the proteasome, which yields a p90 form that lacks
the transmembrane signal or anchor (23, 25, 28–30). How-
ever, p90 remains tethered to the ER through dimerization to
an uncleaved p120, until it is disengaged from its partner by
the “segregase” activity of Cdc48, acting in concert with
Ufd1-Npl4 (24, 31, 32). The released p90 can then travel to the
nucleus, where it activates expression of OLE1 (24). The p90
species are quite unstable, and Cdc48 also promotes their
degradation (33). In addition to acting as a transcription fac-
tor, Mga2 also influences the stability of OLE1 mRNA (34),
although the degree to which this function is carried out by
p90 or p120 is not understood.
EXPERIMENTAL PROCEDURES
Yeast Strains and Growth Conditions—Strains, plasmids, and prim-
ers used in this study are described in supplemental Tables S3–S5. All
yeast strains are derivates of either the wild-type strain RJD 4614
(S288C background from the OpenBiosystems Yeast Knockout Li-
brary) or the wild-type strain RJD 360 (W303 background). For Ubx2
domain analysis experiments, mutants were derived from strains
gifted by Chao-Wen Wang. Standard genetic techniques were used.
Unless otherwise stated, strains were grown at 30 °C and cultured in
yeast extract/peptone/dextrose (YPD).
SILAC Labeling of Cells—For SILAC experiments, strains aux-
otrophic for lysine and arginine were used. Cells expressing
His8ubiquitin were grown in complete synthetic medium with 2%
dextrose containing 20 mg/L lysine and arginine or in “heavy” medium
with 20 mg/L 13C6
15N2-lysine and
13C6-arginine (Cambridge Isotope
Laboratories, Andover, MA). All mutant strains with the exception of
cdc48–3 and ubx2 expressed His8ubiquitin and endogenous ubiq-
uitin in a 1:1 ratio. Cdc48–3 and ubx2 cells expressed lower levels
of His8ubiquitin, which we corrected for during quantification. Cells
were grown for 10 generations to log-phase (OD600 1.0–2.0) and
equal amounts of the light and heavy-labeled cells (as determined by
OD600) were mixed, harvested, washed, and flash frozen.
Purification of Ub Conjugates—Purifications were performed sim-
ilarly to the protocol described previously (35). Two hundred OD600
units of cells were lysed in urea buffer (8 M urea, 300 mM NaCl, 100 mM
Na2PO4, 10 mM Tris-HCl pH 8.0, 0.2% Triton X-100, 20 mM imidazole,
and 5 mM N-ethylmaleimide (NEM)) by vortexing with glass beads.
Ubiquitinated proteins were purified by the addition of nickel-NTA
bead slurry (50 l beads/5-10 mg of lysate) to clarified lysate (13,200
rpm for 15 min in an eppendorf Centrifuge 5417R) and mixed at room
temperature for 90 min. Beads were washed three times with 20 bed
volumes of buffer. A two-step digestion was performed directly on
proteins bound to the beads by first digesting with Lys-C for 4 h,
followed by overnight digestion with trypsin (36).
Fractionation and Liquid Chromatography-tandem MS (LC-MS/
MS)—The tryptic peptides were desalted on a C18 macrotrap
(Michrom Bioresources, Auburn, CA) and concentrated in vacuo.
Dried samples were resuspended and subjected to StageTip-based
strong anionic exchange (SAX) as previously described (37). Samples
were eluted, concentrated, and then acidified before mass spectro-
metric analysis. Mass spectrometry experiments were performed on
an EASY-nLC (Thermo Scientific) connected to a hybrid LTQ-Orbitrap
Classic with a nanoelectrospray ion source (Thermo Scientific) using
a setup and settings (38) very similar to those previously described
(39). Binding and separation of the peptides took place on a 15 cm
silica analytical column (75 m ID) packed in-house with reversed
phase ReproSil-Pur C18AQ 3 m resin (Dr Maisch GmbH, Ammerbuch-
Entringen, Germany). Samples were run for 240 min on a 5% to 25%
acetonitrile gradient in 0.2% formic acid at a flow rate of 350 nL per
minute. The mass spectrometer was programmed to acquire data in
a data-dependent mode, automatically switching between full-scan
MS and tandem MS acquisition. Survey full scan MS spectra (from
m/z 300 to 1700) were acquired in the Orbitrap after the accumulation
of 500,000 ions, with a resolution of 60,000 at 400 m/z. The ten most
intense ions were sequentially isolated, and after the accumulation of
5000 ions, fragmented in the linear ion trap by collision-induced
dissociation (CID) (collisional energy 35% and isolation width 2 Da).
Precursor ion charge state screening was enabled and singly charged
and unassigned charge states were rejected. The dynamic exclusion
list was set for a 90 s maximum retention time, a relative mass window
of 10 ppm, and early expiration was enabled.
Mass Spec Analysis and Quantification—Thermo raw data files
were analyzed by MaxQuant (v 1.3.0.5) (40) and were searched
against the SGD yeast database (5911 sequences) and an in-house
contaminant database (259 sequences) including human keratins and
proteases. All default options were used except as follows: match
between runs was enabled (2 min maximum), GlyGly on Lys
(114.042927), and multiplicity of 2 with heavy labels Arg6
(6.020129) and Lys8 (8.014199). Tryptic digest was specified with
up to two missed cleavages. Initial precursor mass tolerance was 7
ppm, however MaxQuant calculates tighter individual precursor tol-
erances after recalibration. Fragment ion tolerance was 0.5 Da. Pep-
tide, protein, and site false discovery rates were fixed at 1% using the
target-decoy approach with a reversed database (40). The minimum
number of peptides for quantification was 1. Spectra for the small
number of proteins identified by a single peptide are included in the
supplemental Material section. Further data processing was per-
formed to calculate ratios and standard errors of the ratios for each
mutant using in-house scripts described previously (41). Briefly, hier-
archical models are constructed for each mutant, in which the overall
ratio for each protein is the geometric mean of the biological repli-
cates and the biological replicate ratio is the median of all of the
peptide ratios in the replicate. The standard error of the overall protein
ratio is calculated by estimating the global peptide ratio standard
error using pooled variance (calculated separately for peptide ratios
based on requantified isotopic patterns) and using a bootstrapping
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procedure to resample at each level in the hierarchical model. In
cases in which the protein replicate ratios are inconsistent (i.e. up-
regulated in one sample and down-regulated in another), the standard
error would be very large and the protein would not be considered
significantly changed from 1:1.
To calculate a p value for the number of significantly elevated
proteins in at least one experiment, a bootstrapping method was
employed. For each bootstrapping iteration, the ratios observed were
randomly reassigned to proteins. Next, the pooled variance was
calculated based on these reassigned ratios and the hierarchical
models were recomputed. Finally, we counted the number of proteins
that were significantly elevated using the same criteria as with the real
data. A thousand bootstrap iterations were calculated. In most boot-
strap iterations, no proteins were found to be significantly elevated in
any experiment. We then modeled the distribution of counts of sig-
nificantly enriched proteins with a Poisson distribution.
All quantified proteins were used to construct Figs. 1B and sup-
plemental Figs. S1A, S1B. Proteins for which the probability that they
changed more than 10% in the WT/WT control experiment was
99% or were not significantly enriched (p value 0.05) in the His8Ub
expressing cells compared with the untagged control cells were
filtered out because of the high likelihood that they would yield false
positive identifications in the mutant/wild type comparisons. Analyses
relating to comparisons with the Saccharomyces cerevisiae ubiquitin
database (SCUD) and the response of the ubiquitination enzymes in
the cdc48–3 mutant used all proteins not filtered out. All proteins not
filtered out that were quantified in all mutants were used in the
remaining bioinformatic analyses. In Figs. 1C and 1D, we considered
proteins to be significantly changed if there was a less than 1%
chance that the fold change was less than 10% based on the indi-
vidual protein standard error. Yeast GO-Slim annotations for Figs. 2A
and 2B were downloaded from the SGD. Proteins considered signif-
icantly enriched had a more than 10% change from 1:1 (p value 
0.05). Annotations for supplemental Fig. S3A and supplemental Figs.
S4A-S4E were downloaded from DAVID (42, 43). Displayed terms
were deemed significantly different at a p value  0.05 (e.g. the 25th
percentile of the ratios of the proteins annotated with the term was
significantly greater than random) after correcting for multiple hypoth-
eses testing using the Benjamini and Hochberg method(44).
Confirmation of Ub Conjugate Accumulation for Spt23—Ubiquitin
conjugates were purified from 100 OD600 units of cells expressing
tagged ubiquitin as described in the purification of Ub conjugates
section. However after washing beads an equal volume of 2 SDS-
PAGE buffer was added before boiling the beads for 5 min to elute
conjugates. Boiled aliquots were resolved by SDS-PAGE and immu-
noblotted for endogenously tagged mycSpt23V5.
Confirmation of Ub Conjugate Accumulation for Mga2—Cells (100
OD600 units) were disrupted using a FastPrep-24 in lysis buffer con-
taining 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 10 mM
NEM, 0.5 mM AEBSF, and Protease Inhibitor Mixture Tablet (Roche).
Lysates were clarified by centrifugation (14,200 rpm for 20 min in an
Eppendorf Centrifuge 5417R) and bound to 30 l of TUBE2 agarose
beads (Boston Biochem, Cambridge, MA)/5–10 mg lysate for 2–3 h
with rotation at 4 °C. Beads were washed three times with lysis buffer
and an equal volume of 2X SDS-PAGE buffer was added before
boiling the beads for 5 min to elute conjugates. Boiled aliquots were
resolved by SDS-PAGE and immunoblotted.
Quantitative Reverse Transcription PCR—RNA was isolated from 3
OD600 units of cells using Trizol (Invitrogen) according to the manu-
facturer’s recommendations. cDNA was prepared using the Super-
script first strand synthesis kit (Invitrogen) and quantitative PCR was
performed using the SYBR GreenER super mix (Invitrogen) with prim-
ers described in supplemental Table S5.
Immunoblot Analysis—Cell pellets were first boiled for 3 min and
then after the addition of SDS-PAGE buffer supplemented with 5 mM
NEM and glass beads, lysed by vortexing in a Fast Prep-24 (MP) for
1 min at a setting of 6.5 and boiled again for 3 min. Boiled lysates
were centrifuged at 16,000  g for 5 min. Aliquots were resolved by
SDS-PAGE, transferred to nitrocellulose, and stained with Ponceau S
to determine equivalent loading of protein extracts. The nitrocellulose
filters were immunoblotted with desired antibody and developed
by ECL or SuperSignal (Invitrogen). For detecting mycSpt23V5,
mycSpt23HA, and mycMga2, anti-myc (Covance), anti-V5 (Invitrogen),
and anti-HA (16B12, Roche) antibodies were used at a dilution of
1:3000. Other immunoblots were performed with antibodies spe-
cific for Ubiquitin (Stressgen Biotechnologies, Victoria, BC, Can-
ada) dilution 1:1000, Dpm1 (Invitrogen) dilution 1:3000, tubulin
(Santa Cruz, Santa Cruz, CA) dilution 1:30000, TAP tag (Thermo
Scientific) dilution 1:3000, Rsp5 (gift from Linda Hicke) dilution
1:3000, Cdc48 (gift from Thomas Sommer and Ernst Jarosch) dilu-
tion 1:1000, and Ufd1 (custom polyclonal antibody from Covance)
dilution 1:10000.
Growth Assays—For plating assays cells were grown in YPD or
SRaffinose-URA and diluted to OD600 of 0.3 in water. Serial fivefold
dilutions were prepared in water and spotted onto YPD  0.2% oleic
acid or minimal medium plates supplemented with various additives
as described in the text. Plates were incubated at 30 °C or 37 °C for
2–4 days.
Turnover of Spt23—RJD 6138, 6139, and 6167 cells were grown in
YPD to an OD600 1.0, at which point 100 g/ml cycloheximide was
added to initiate a chase. Samples were taken at the time points
indicated. To monitor Spt23 following the switch from medium con-
taining oleic acid to medium lacking oleic acid, cells were grown in
YPD  0.2% oleic acid, washed in water, and resuspended in YPD
supplemented with cycloheximide. Proteins were extracted as de-
scribed in the Immunoblot Analysis section with boiling SDS-PAGE
buffer supplemented with 5 mM NEM. Lysates were resolved by
SDS-PAGE and immunoblotted.
Immunoprecipitation of Ubx2—RJD 3166, 6172, 6173, and 4614
were grown in YP plus 2% galactose (to induce expression of
mycSpt23HA from theGAL promoter) to an OD6001.0, harvested, and
flash-frozen in liquid nitrogen. Cells were lysed by grinding in liquid
nitrogen. Frozen cell powder was resuspended in lysis buffer contain-
ing 50 mM Tris (pH 7.5), 100 mM NaCl, 1 mM EDTA, 5 mM Mg(OAc)2,
0.2% Triton X-100, 5 mM NEM, and Protease Inhibitor Mixture Tablet
(Roche), clarified by centrifugation (14,200 rpm for 20 min on an
Eppendorf Centrifuge 5417R) and bound to rabbit IgG conjugated to
superparamagnetic Dynabeads (Invitrogen) for 3 h with mixing at
4 °C. Beads were washed three times with lysis buffer and bound
proteins were eluted by boiling in SDS-PAGE buffer and resolved by
SDS-PAGE before immunoblotting.
Immunofluorescence—RJD 6172 and 6182 cells were grown in YP
plus 2% galactose (to induce expression of mycSpt23HA from the GAL
promoter) to an OD600 0.5–1.0. Cell cultures were adjusted to 4%
formaldehyde and incubated for 15 min before cells were collected,
washed, and spheroplasted by treatment with 50 units of lyticase
(Sigma) for 10 min. Spheroplasts were washed and placed on ConA-
coated glass slides. Cells were permeabilized with methanol and
acetone washes. Cells were treated with blocking buffer (2% BSA,
0.1% Tween20 in PBS) and incubated with primary antibody over-
night at a dilution of 1:1000. FITC-conjugated secondary antibody
was added and cells were incubated for another hour followed by
DNA staining with DAPI. Mounting medium was placed on cells and
images were taken with a Zeiss confocal microscope with a 100
objective.
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RESULTS
Identification and Quantification of Changes in the Ubiquitin
Proteome—To better understand the breadth of function of
Cdc48 and its adaptors that contain an UBX domain, we
sought to identify ubiquitin conjugates whose levels increased
in yeast cells deficient in these components. The rationale
underlying this approach is based on the observation that
ubiquitinated Rpb1 substrate accumulates in ubx5 and
cdc48-3 cells (18). Wild type and mutant yeast cells express-
ing His8-tagged ubiquitin were labeled with heavy and light
lysine and arginine, respectively, and immediately before har-
vesting and lysis the cultures were mixed. Ubiquitin conju-
gates were purified on Ni2-NTA magnetic beads under de-
naturing conditions (8 M urea) and digested with trypsin. The
resulting peptides were subjected to strong anionic exchange
(SAX) fractionation before sequencing in a mass spectrometer
(Fig. 1A). We performed this analysis in triplicate with cdc48-3
and in duplicate with six of the seven ubx mutant strains
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FIG. 1. Sequencing and quantification of the ubiquitin proteome reveals proteins regulated by Cdc48 and its UBX domain adaptors.
A, Experimental workflow for identification and quantification of Ub conjugates. Proteins were quantified using the SILAC method. Light (WT) and
heavy (mutant) isotope labeled cells constitutively expressing His8Ub were grown, collected in log-phase, and mixed. The cells were lysed in
denaturing urea buffer and ubiquitinated proteins were purified with nickel-NTA magnetic beads. Proteins were digested into peptides, which were
fractionated via strong anionic exchange and analyzed by mass spectrometry. B, Smoothed histogram depicting changes in the ubiquitinated
proteome in mutants.C, Heatmap of relative changes to the ubiquitin proteome in various mutants. Only proteins that exhibited a significant change
from a 1:1 ratio (mutant/wild type) in at least one experiment are colored. Abundance changes were deemed significant if the mutant/wild type ratio
deviated from 1:1 with a p value less than .05 corrected for multiple hypothesis testing by the Benjamini and Hochberg method (44). D, Graphical
representation of how frequently an ubiquitin conjugate found to accumulate in the query mutant also accumulated in other mutants.
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(ubx2-ubx7; shp1/ubx1 was not analyzed because it
grew so poorly).
To evaluate the reproducibility of our methodology we com-
pared biological replicates (supplemental Figs. S1A, S1B),
which revealed that our data sets were highly correlated and
demonstrated low coefficients of variation. To improve further
the quality of our proteomic data set, we performed two
separate control experiments, the results of which were used
to computationally filter our data before further analysis. In the
first experiment both the light and heavy-labeled cultures
were wild type. This analysis yielded a narrow distribution of
heavy/light ratios centered on 20, confirming the significance
of the broader ratio distributions seen in the wild type/mutant
comparisons (Fig. 1B, supplemental Fig. S2A). Proteins that
exhibited ratios that deviated from 20 by 10% (p value
0.01) in this control experiment were excluded from our
overall data set. In the second control, we compared un-
tagged, light-labeled cells and His8Ub-expressing heavy-la-
beled cells. Proteins that were significantly enriched in the
His8Ub-expressing cells (p value0.05) were deemed to be
derived from bona fide ubiquitin conjugates. After computa-
tional filtration, our data set contained ratios (ranging between
0.018 and 53.3) for 1916 ubiquitinated proteins identified and
quantified at least once and 1733 ubiquitinated proteins iden-
tified in at least one replicate of each mutant/wild type com-
parison (all proteins identified are listed in supplemental Table
S1, supplementary File S1 and S2). In the ubx2 (1, 677),
ubx3 (1, 701), ubx4 (1, 707), ubx5 (1, 581), ubx6 (1, 683),
and ubx7 (1, 625) experiments the indicated number of
proteins (out of 1733 possible) were identified in both repli-
cates. In the cdc48-3 experiments, 1588 of the 1733 proteins
were identified in triplicate. We additionally identified 67 di-
glycine peptide signatures, which are indicative of ubiquitina-
tion sites; 25 of the 67 were previously identified (supplemen-
tal Table S2, supplementary File S3 and S4). The proteins in
this study covered over 50% of the previously identified ubiq-
uitinated proteins in the SCUD (http://scud.kaist.ac.kr/) and
included 1226 proteins not previously listed (supplemental
Fig. S2B). These metrics suggest that we have sampled a
substantial portion of the ubiquitinated proteome.
UBX Proteins Target Different Subsets of Ubiquitin Conju-
gates—From the initial screen it was evident that cdc48-3 and
ubx mutations had wide-ranging and variable effects on the
ubiquitin proteome. Comparison of the ratio distributions of
the different experiments underscores this conclusion (Fig.
1B). Consistent with Cdc48 being the hub of its eponymous
network, cdc48-3 had the greatest effect on the ubiquitinated
proteome. Twenty-six percent of ubiquitin conjugates were
detected at higher levels in cdc48-3 compared with wild type
cells whereas 17% were decreased in amount. We do not
know the reason for the latter but it could be because of
reduced expression of the protein or increased competition
for free ubiquitin, because total conjugated ubiquitin in-
creases substantially in cdc48-3 cells (18). Among the ubx
mutants ubx5 and ubx6 caused the strongest perturba-
tions; by contrast ubx3 had the least effect, followed by
ubx4. To evaluate the impact of the cdc48-3 and ubx
mutations with more granularity, we generated a heatmap that
captures the behavior of the changing conjugates quantified
in all experiments in our data set (Fig. 1C). Three important
points are evident in this graphic. First, ubx6 and ubx7
displayed remarkable overlap with over 85% of the ubiquitin
conjugates accumulating in ubx7 also accumulating in
ubx6. Very little is known about Ubx6 and Ubx7 but this
result is consistent with their close homology and colocaliza-
tion at the perinuclear membrane (45). Second, cdc48-3 mu-
tants accumulated a set of ubiquitin conjugates (128 proteins)
that did not accumulate in any single ubx mutant. This
suggests that many substrates may engage Cdc48 without an
Ubx protein, and could explain why a relatively low fraction of
Cdc48/p97 substrates have been shown to be dependent on
an UBX domain cofactor. Third, with the exception of ubx6
and ubx7, the different mutations had markedly different
effects on the ubiquitin conjugate proteome. This conclusion
was also supported by an independent analysis (Fig. 1D),
which indicated that for each ubx mutant except ubx6 and
ubx7, 40% of the accumulating conjugates were elevated
only in that mutant and up to 90% were elevated in that
mutant and at most one other mutant. This supports the
hypothesis that individual Ubx proteins target distinct sets of
ubiquitin conjugates, which is consistent with their proposed
role as substrate adaptors for the Cdc48 engine. Remarkably,
of the 1733 proteins in our data set, 62% were elevated
significantly in at least one mutant (62% was highly significant
in comparison to the null hypothesis in which peptide ratios
are randomly assigned to proteins (p value  1e-100)), sug-
gesting that the Cdc48 network has a profound impact on the
UPS that is greater than has been previously appreciated.
Ubiquitin Conjugates that are Elevated in Different ubx
Mutants Map to Diverse Cellular Components and Cellular
Processes—To understand the subcellular localization and
functions of the ubiquitinated species identified in our analy-
ses, we evaluated Yeast GO-Slim cell components and GO-
Slim biological process annotations (Figs. 2A and 2B). Many
different trends were apparent from this analysis. Ubiquitin
conjugates that were elevated in cdc48-3 cells (referred to
hereafter as “cdc48-3 conjugates”) encompassed numerous
known targets including Mga2 and Spt23 (24, 28), the HMG-
CoA reductases Hmg1 and Hmg2 (46), and the Rpb1 subunit
of RNA Polymerase II (18). Consistent with the known roles of
Cdc48 in membrane biology, cdc48-3 conjugates were sig-
nificantly enriched for proteins of the endomembrane system
including the ERP and ERV family of proteins involved in ER to
Golgi transport, members of the GPI family of proteins, sub-
units of the Golgi mannosyltransferase complex, and all seven
proteins of the PMT (Protein o-mannosyltransferase) family.
The cdc48-3 conjugates were also enriched for glycosylated
proteins, enzymes of lipid and carbohydrate metabolism, and
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FIG. 2. Changes to the ubiquitin conjugate proteome in ubxmutants suggest functional specialization of Ubx proteins. A, Overview
of how ubiquitin conjugates that accumulate in cdc48-3 and ubx mutants are distributed according to GO-Slim cell components and (B)
GO-Slim biological processes. All of the proteins analyzed in (A) and (B) demonstrated enrichment greater than 10% (with 95% confidence)
in one or more mutants. C, Box and whisker plot of annotation terms demonstrating a significant enrichment in the Ub-Proteome for a majority
of their identified members in the ubx2 mutant strain. Significance was calculated based on the 25 percentile of the distribution of protein
ratios of protein annotated with the term in comparison to all ubx2 ratios. Enriched GO Cellular Component (CC), GO Biological Process (BP),
GO Molecular Function (MF), and Uniprot Keyword (KW) terms are shown.
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proteins involved in nuclear pore complex, nuclear organiza-
tion, stress response, and the ubiquitin-proteasome system
(supplemental Fig. S3A). Further investigation of the latter
category revealed that cdc48-3 cells contained elevated lev-
els of ubiquitin conjugated species of multiple E3 ubiquitin
ligases and F-Box proteins (supplemental Fig. S3B). This is
consistent with recent identification of Cdc48 as an SCFMet30
disassembly factor (47) and suggests that Cdc48 may be
more widely involved in regulation of SCF complexes.
Analysis of the ubiquitin conjugates that were elevated in
ubx2 relative to wild type cells (i.e. ubx2 conjugates) indi-
cated there was a significant enrichment of vacuolar and
metabolic transport proteins, including secretory proteins
(Fig. 2A–2C). Many of these proteins are synthesized in the
ER, where Ubx2 is localized. Notably, elevated levels of ubiq-
uitinated forms of a number of ER proteins were detected in
both ubx2 and cdc48-3 cells, including members of the
ergosterol biosynthesis pathway and the OLE1 transcription
factors Spt23 and Mga2, consistent with a role for Ubx2-
Cdc48 in regulating lipid metabolism.
Deletion of UBX3 had little impact on the ubiquitin conju-
gate proteome with no proteins changing consistently in a
significant manner. The pool of ubx4 conjugates was like-
wise small but was enriched for ER proteins involved in lipid
metabolism including Spt23, Mga2, Hmg1, and Hmg2 (Figs.
2A, 2B, supplemental Fig. S4A, S4B).
Ubiquitin conjugates that were elevated in ubx5 cells were
enriched for vacuolar and plasma membrane proteins, includ-
ing proteins involved in ion and amino acid transport such as
the TPO family of proteins involved in polyamine transport
(Fig. 2A, 2B, supplemental Fig. S4C). Ubx5 contains an UIM
domain that links it to Rub1-conjugated cullin-RING ubiquitin
ligases (CRLs) (48, 49), raising the possibility that a CRL
regulates trafficking of membrane proteins in yeast.
Lastly, ubiquitin conjugates that were elevated in ubx6
and ubx7 were highly enriched for nucleolar and ribosomal
proteins, including proteins involved in ribosome assembly
(Fig. 2A, 2B, supplemental Fig. S4D, S4E). In agreement with
a nuclear and nucleolar function, Ubx6 and Ubx7 localize to
the nuclear periphery and nucleus (45).
Ubiquitinated Spt23 and Mga2 Accumulate in ubx2—The
increase in ubiquitinated Spt23 and Mga2 species in cdc48-3,
ubx2 and ubx4 cells (Fig. 3A) piqued our interest because
although it was already known that Cdc48-Ufd1-Npl4 pro-
motes release of Spt23 and Mga2 from the ER membrane and
ubiquitinated forms of these transcription factors accumulate
in cdc48, npl4, and ufd1 cells (24, 25, 28, 31), Ubx proteins
had not previously been implicated in this pathway. To eval-
uate the ubiquitination status of Spt23 in ubx2 and ubx4
mutants, we first generated a yeast strain in which endoge-
nous SPT23 was modified to express proteins bearing an
N-terminal myc tag and C-terminal V5 tag (mycSpt23V5). We
then used Ni2-NTA magnetic beads to purify ubiquitin con-
jugates from mycSPT23V5 strains expressing His8-tagged
ubiquitin. Immunoblotting for tagged Spt23 revealed robust
accumulation of high molecular weight conjugates in both
ubx2 and ubx4 as compared with wild type (Fig. 3B). For
reasons we do not understand, overexpression of His8Ub al-
tered accumulation of ubiquitin conjugates on mycSpt23V5; in
the presence of His8Ub ubx4 accumulated more ubiquiti-
nated mycSpt23V5 than ubx2 whereas in the absence of
His8Ub the reverse was observed (e.g. Fig. 5A, 5B). To evalu-
ate the ubiquitination status of Mga2 in ubx2 and ubx4
mutants, we used Tandem Ubiquitin Binding Entity (TUBE2)
beads to purify endogenous ubiquitin conjugates from strains
transformed with a plasmid that expressed Mga2 with a myc
tag appended to its N terminus (mycMga2). Immunoblotting
for mycMga2 revealed an accumulation of high molecular
weight conjugates in ubx2 cells compared with wild type
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FIG. 3. Ubiquitin-conjugated forms of Spt23 and Mga2 accumu-
late in ubx2 cells. A, Table of Spt23 and Mga2 SILAC ratios in
ubx2:WT and ubx4:WT comparisons. The reported ratios incorpo-
rate many independent measurements (Spt23 ubx2: 7, ubx4: 24;
Mga2 ubx2: 21, ubx4: 37). B, Validation of Spt23 ubiquitin conju-
gate accumulation. Ubiquitin conjugates in WT, ubx2, and ubx4
cells expressing mycSpt23V5 from the natural locus and His8Ub from a
plasmid were purified with nickel-NTA magnetic beads. The input
extract and bound fractions were immunobloted for the myc epitope,
Ub, and tubulin (input loading control) as indicated.
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(supplemental Fig. S5). By contrast, few if any high MW ubiq-
uitin conjugates of Mga2 were detected in ubx4 cells.
Ubx2 is a Component of the OLE1 Pathway—In rapidly
growing cells that are producing lipids for membrane assem-
bly, the transmembrane p120 forms of Spt23 and Mga2 are
ubiquitinated by the ubiquitin ligase Rsp5 and cleaved by the
proteasome (23). Subsequently, Cdc48-Ufd1-Npl4 promotes
release of cleaved p90 forms of Spt23 and Mga2 from the ER
membrane, allowing these proteins to translocate to the nu-
cleus where they activate transcription of OLE1, which en-
codes the essential enzyme that generates UFAs (26). The
accumulation of ubiquitin-conjugated Spt23 and Mga2 in
ubx2 raised the question of whether Ubx2 also functions in
this pathway. To address this question we first tested for
genetic interactions between rsp5-1 and ubx mutants. Sim-
ilar to the previously reported synthetic lethality of cdc48 and
ufd1 with rsp5 (24), ubx2 rsp5-1 cells failed to grow on YPD
at 30 °C but were rescued by addition of the UFA oleic acid
(Fig. 4A). By contrast, ubx4 rsp5-1 did not exhibit synthetic
lethality. To test more directly the hypothesis that Ubx2 pro-
motes expression of OLE1, we measured OLE1 mRNA levels
in mutants grown in YPD. During normal log-phase growth in
YPD, ubx2 cells showed a fivefold reduction in OLE1 mRNA
(Fig. 4B). Moreover, as was previously reported for rsp5 mu-
tants (23), both ubx2 and rsp5 cells failed to accumulate
OLE1 mRNA on being shifted from a medium containing oleic
acid to a medium lacking UFAs (Fig. 4C). By contrast, ubx4
was not defective in OLE1 regulation and did not exacerbate
the effect of ubx2 (Figs. 4B, 4C).
The results above suggested that Ubx2 is involved in acti-
vation of Spt23 and Mga2. As further confirmation, we exam-
ined the effect of Spt23 and Mga2 overexpression in mutant
cells (Fig. 4D). Although UFAs are required for survival, the
excess production of oleic acid that occurs on hyperactivation
of OLE1 expression is toxic (50). Whereas overexpression of
Spt23 or Mga2 from a galactose-inducible promoter inhibited
growth of wild type cells, ubx2 cells, like rsp5-1 cells (51),
were more tolerant (Fig. 4D), even though they equally over-
expressed these OLE1 activators (data not shown).
Ubx2 Regulates Processing of Spt23—We next wanted to
determine if Ubx2 is involved in processing of the OLE1
activators from their p120 precursor forms to their p90 active
forms. For these experiments we focused on Spt23 because
we found it difficult to consistently detect tagged Mga2 ex-
pressed from its endogenous locus. We examined steady
state levels of mycSpt23V5 in YPD-grown cells deficient in
various components of the Cdc48 and proteasome pathways
(Fig. 5A). As anticipated from prior results (24), the cim3-1 and
rsp5-1mutants exhibited a severe defect in p90 accumulation
(Fig. 5A, 5B; cim3-1 is a temperature-sensitive allele of the
gene that encodes proteasome subunit Rpt6). Notably, p90
accumulation was also significantly impaired in cdc48-3 and
ufd1-2 strains. In ubx2 (Fig. 5A, 5B) but not in other ubx
mutants (Fig. 5B), ubiquitinated high MW forms of mycSpt23V5
accumulated and the p90:p120 ratio was significantly re-
duced. However, the degree to which processing to p90 was
defective varied in different experiments. In the prevailing
model, Cdc48-Ufd1-Npl4 acts primarily after the proteasome
to promote release of p90 from the ER membrane (24, 31, 52).
However, it has also been reported that Cdc48-Ufd1-Npl4 is
required for processing of p120 to p90 (25). Our data are
consistent with those of Hitchcock et al. and suggest that
Cdc48-Ufd1 and Ubx2 make important contributions to effi-
cient formation of p90.
After establishing a role for Ubx2 in Spt23 processing, we
next investigated the contribution of its UBA and UBX do-
mains to this reaction. We immunoblotted for mycSpt23V5 in
ubx2 strains in which full-length and various deletion mu-
tants of UBX2were integrated at the LEU2 locus under control
of the UBX2 promoter (53) (Fig. 5C). This experiment con-
firmed that the defect in Spt23 processing in ubx2 cells was
because of lack of Ubx2, and suggested that the UBX domain
FIG. 4. Ubx2 promotes inducible expression of OLE1. A, Syn-
thetic lethality of rsp5-1 and ubx2mutations. Fivefold serial dilutions
of WT, rsp5-1, ubx2, ubx4, rsp5-1 ubx2, and rsp5-1 ubx4 cells
were plated on YPD and YPD0.2% oleic acid and incubated at
30 °C or 37 °C for 2 days. B, C, Expression of OLE1 mRNA in ubx2
cells grown in YPD (B) or grown first in YPD 0.2% oleic acid and
shifted to YPD for two hours (C). RNA from cells grown to log-phase
in YPD medium was used for RT-qPCR to assess OLE1mRNA levels.
Values were normalized to ACT1. Error bars denote S.D.; n  2. D,
Toxicity because of Spt23 and Mga2 overexpression is suppressed
by ubx2. WT, ubx2, and ubx4 strains transformed with a 2 m
plasmid that contains either GAL-SPT23 or GAL-MGA2 were plated
onto YPD and synthetic dextrose- or galactose- containing media and
grown for 4 days at 30 °C.
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FIG. 5. Ubx2 regulates processing and stability of the transcription factor Spt23. A, Steady-state level of Spt23 in OLE1 pathway
mutants. The indicated mutant strains expressing mycSpt23V5 from the endogenous locus were grown in YPD at 30 °C (ubx2, ubx4, and
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anti-V5, and anti-tubulin antibodies. B, Steady-state levels of Spt23 in ubxmutants. The indicated strains were grown in YPD at 30 °C (except
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played a more important role in processing than the UBA
domain. RT-PCR analysis of these same strains grown in oleic
acid and switched to oleic acid-free medium revealed a large
decrease in OLE1mRNA induction in the UBA UBXmutant
but not the single mutants (data not shown).
Ubx2 is orthologous to human Ubxd8, which may directly
sense UFAs (54, 55). We therefore tested whether Ubx2 was
required to sense UFAs in yeast. To address this question we
grew wild type and mutant cells with and without oleic acid
and evaluated processing of mycSpt23V5. We reasoned if
Ubx2 is required to sense UFAs, that the reduced level of p90
formed in ubx2 would be insensitive to their presence. Proc-
essing of mycSpt23V5 in wild type cells was strongly repressed
by addition of oleic acid (Fig. 5D). Likewise, the residual
formation of p90 observed in cim3-1, cdc48-3, and ubx2
cells remained sensitive to inhibition by oleic acid. Consistent
with this, our analysis of OLE1 mRNA revealed that although
its levels were severely reduced in ubx2 and ubx2 ubx4,
they were diminished further on addition of oleic acid (Fig.
4C). Taken together, these data indicate that there must be at
least one UFA sensor that remained in ubx2 cells. Careful
inspection of the modification state of mycSpt23V5 in cdc48-3
and ubx2 cells grown with or without oleic acid suggested
that sensing of UFAs occurred at or before Rsp5-dependent
ubiquitination (Fig. 5D).
To investigate in greater depth the role of Ubx2 in Spt23
processing, we performed cycloheximide chase experiments
(Fig. 5E). The p90 form of mycSpt23V5 was rapidly degraded in
wild-type but was modestly stabilized in ubx2 and strongly
stabilized in cdc48-3 cells. By contrast, p120 was more stable
than p90 in all conditions whereas the high MW ubiquitin
conjugates that accumulated in ubx2 and cdc48-3 were
rapidly metabolized. Given that: (1) p90 was unstable in wild
type, (2) more than half of mycSpt23V5 detected at zero-time in
wild type was processed to p90, and (3) conversion of p120 to
p90 was very slow and inefficient, we suggest that in wild type
cells grown at 30 °C p120 became conjugated with ubiquitin
and rapidly processed to p90 either during or very shortly after
completion of synthesis, such that newly synthesized mole-
cules that escaped modification were largely refractory to
subsequent processing.
Ubx2 Associates with Spt23 and affects its Subcellular Lo-
calization—To test whether the effects of ubx2 on Spt23
were likely to be direct, TAP-tagged Ubx2 was immunopre-
cipitated from cells and immunoblotted for associated pro-
teins (Fig. 6A). This experiment revealed a direct interaction
between Ubx2 and unmodified p120 as well as higher MW
ubiquitinated mycSpt23HA. Additionally, as expected (33),
Cdc48 and Ufd1 were detected at levels above background in
the Ubx2TAP immunoprecipitate, as was Rsp5, which had not
previously been shown to interact with Ubx2.
To address the effect of ubx2 on subcellular localization of
Spt23, we performed immunofluorescence on cells that ex-
pressed a pulse of mycSpt23 from the GAL1 promoter (at-
tempts to detect mycSpt23V5 expressed from the natural locus
were unsuccessful). Consistent with our observation that
Ubx2 was required for OLE1 expression, mycSpt23 demon-
strated a decrease in localization to the nucleus in most
ubx2 cells (Fig. 6B). Additionally, in 45% of ubx2 cells,
Spt23 was observed to accumulate in cytosolic punctae (Fig.
6C). Although we do not understand their exact molecular
nature, the existence of these punctae in ubx2 together with
poor nuclear accumulation point to a role for Ubx2 in proper
localization of Spt23.
DISCUSSION
The Cdc48 Network Plays a Broad Role in Shaping the
Ubiquitin Conjugate Proteome—To address globally the im-
pact of Cdc48 and its Ubx adaptors on the UPS, we evaluated
changes to the ubiquitin conjugate proteome in yeast cells
deleted for individual UBX genes or carrying a temperature-
sensitive cdc48-3 allele. Our findings support a broad role for
the Cdc48 network in the UPS. Overall, we identified 1,916
putative ubiquitin conjugates and 1,733 were quantified in all
experiments. Of the 1733, over 62%were found at statistically
significant elevated levels relative to wild type in at least one
of the mutant strains. Mutation of different UBX genes led to
markedly distinct effects on the ubiquitin conjugate proteome.
For example, our findings suggested novel and unexpected
roles for Ubx2, Ubx5, and Ubx6/7 in regulation of vacuolar,
plasma membrane, and nucleolar/ribosomal proteins, respec-
tively. However, only a fraction of ubiquitin conjugates anno-
tated with a given term were up-regulated in a particular ubx
mutant (e.g. not all ubiquitin-conjugated vacuolar proteins
were found at increased levels in ubx2). Thus, localization
alone does not render a ubiquitin conjugate subject to regu-
lation by a particular Ubx cofactor.
Our approach assumes that ubiquitin conjugates that are
elevated in a particular mutant relative to wild type repre-
sent intermediates that accumulate on attenuation of Cdc48
activity or deletion of the adaptor that normally links them to
Cdc48. However, increased levels of a conjugate may arise
for cim3–1 at 37 °C) and analyzed as in (A). ubx2/4 indicates an ubx2 ubx4 double mutant. C, Influence of Ubx2’s UBA and UBX domains
on the steady-state level of Spt23. Same as (A) except that strains in lanes 2–6 were ubx2 bearing a copy of full-length (FL) UBX2 or a version
lacking the indicated domain integrated at LEU2. D, Effect of UFAs on modification and processing of Spt23 in various mutants. Same as (A)
except that strains were grown in normal medium or medium supplemented with 0.2% oleic acid as indicated. Cells were grown at 30 °C
(ubx2) and 37 °C (cdc48-3). E, Role of Ubx2 and Cdc48 in p90 degradation. Wild type, ubx2, and cdc48-3 cells expressing mycSpt23V5 from
the endogenous locus were grown in YPD at 30 °C (left panel) or at 25 °C followed by a shift to 37 °C for 2 h (right panel) before addition of
cycloheximide to initiate a chase. At the indicated times (minutes) cells were harvested and processed for SDS-PAGE followed by immuno-
blotting with anti-myc, or anti-tubulin antibodies.
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from increased expression of the protein. Of interest, numerous
ubiquitin conjugates were selectively depleted in specific ubx
strains. This was not investigated further, but during the course
of this work it was reported that the human UBX protein SAKS1
protects ERAD substrates from deubiquitination (56) and over-
produced UBXD7 binds to and increases the fraction of Nedd8-
conjugated Cul2 in human cells (48, 49). Hence, the large num-
ber of conjugate depletion events that we observed in ubx
cells may represent species whose ubiquitin-conjugated forms
are stabilized on binding of Ubx proteins. Our extensive dataset
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were subjected to anti-TAP immunoprecipitation (IP) and the immunoprecipitates and input lysates were immunoblotted (IB) for TAP,
mycSpt23HA, Cdc48, Ufd1, and Rsp5. Input extracts were also blotted for tubulin. B, Immunofluorescence localization of Spt23 in WT and ubx2
cells. WT (RJD 6172) and ubx2 (RJD 6182) cells expressing Spt23 from the GAL promoter were grown at 30 °C for 6 h in YP plus 2%
galactose. All forms of Spt23 containing an intact N terminus were detected with anti-myc antibody and the nucleus was marked by staining
DNA with DAPI. Nomarski optics (DIC) were used to identify the outline of each cell. C, Quantification of fraction of cell population with from
(B) that contain Spt23 punctae. Seven fields of 300 cells were counted per strain. Error bars denote S.D.
Cdc48 Network Ubiquitin Proteomics
Molecular & Cellular Proteomics 12.10 2801
provides a rich resource for future investigations into this and
other questions related to the functions and regulation of the
Cdc48 network.
Ubx2 and Cdc48 Promote Proteasome-Dependent Proc-
essing of Spt23—Prior work from the Jentsch and Haines
laboratories emphasized a role for Cdc48-Ufd1-Npl4 in re-
lease of the processed forms of Spt23 (24) and Mga2 (31)
from the ER membrane. By contrast, data from the Silver
laboratory emphasized an upstream role for Cdc48-Ufd1-
Npl4 in processing of both proteins (25). Our data support a
role for Cdc48-Ufd1 and Ubx2 in both steps. We observe
diminished levels of p90 in mutant cells. However, the re-
duced p90 accumulation in ubx2 is variable and is less
striking than the defect in OLE1 induction. We propose that
Cdc48-Ufd1-Npl4-Ubx2 acts sequentially to promote both
the processing of Spt23 p120 to p90, and localization of p90
to the nucleus. A prominent role for Cdc48-Ufd1 and Ubx2 in
proteasome-dependent cleavage of p120 resonates with data
on other Cdc48-proteasome substrates, which consistently
place Cdc48/p97 function upstream of (or contemporaneous
with) the proteasome. Sequential roles for Ubx2 in the forma-
tion and activation of p90 helps explain why ubx2 exhibits
such a severe defect in OLE1 regulation.
Consistent with the prior data on rsp5 mutants (24), ubx2
cells are severely deficient in induction of OLE1 expression
and double mutants deficient in Ubx2 and Rsp5 activity fail to
grow on normal medium at 30 °C but are rescued by the
addition of oleic acid, pointing to a crucial role for Ubx2 in
maintaining sufficient Ole1 activity to meet the cellular re-
quirement for UFAs. An important and interesting question
that remains unresolved is, how are levels of fatty acids
sensed so that the cell maintains an appropriate ratio of
SFAs:UFAs? Addition of exogenous UFAs suppresses proc-
essing of p120 to p90 by the Rsp5-Ubx2-Cdc48 pathway,
which reduces expression of the desaturase enzyme en-
coded by OLE1. It was suggested in prior work that the
human ortholog of Ubx2, UBXD8, directly senses UFAs (54,
55, 57). However, addition of UFAs suppresses accumula-
tion of ubiquitinated Spt23 and further reduces the residual
expression of OLE1 in ubx2, indicating that these cells
retain the ability to sense UFAs. Thus, if Ubx2 is a fatty acid
sensor, it cannot be the only sensor in the OLE1 pathway.
Very recently, it was reported that Ire1 serves as a sensor for
membrane lipid saturation in mouse cells (58). Our data
suggest that either Rsp5 itself or a step upstream of Rsp5-
dependent ubiquitination must be capable of sensing UFAs.
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